Steven Y Hua Selected Research

Steven Y Hua Research Topics

2	Neoplasms (Cancer) 01/2020 - 10/2018
2	Rheumatoid Arthritis 01/2018 - 01/2018
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2008 - 01/2007
2	Ocular Hypertension (Glaucoma, Suspect) 10/2008 - 01/2007
1	Eosinophilic Esophagitis 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Ulcerative Colitis 01/2021
1	Infections 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Injection Site Reaction 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Myocardial Infarction 01/2018
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2013
1	Glaucoma 06/2008
1	Hyperemia 01/2007

3	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 02/2013
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2021 - 01/2020
2	ozanimodIBA 01/2021 - 01/2020
2	Biosimilar PharmaceuticalsIBA 01/2018 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2018
2	Biological ProductsIBA 01/2018 - 01/2018
2	brinzolamide (Azopt)FDA Link 10/2008 - 06/2008
1	Interleukin-13IBA 01/2021
1	cendakimabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	PF-06650808IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	PF-06410293IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	GP1111IBA 01/2018
1	Infliximab (Remicade)FDA Link 01/2018
1	Adalimumab (Humira)FDA Link 01/2018
1	Inotuzumab OzogamicinIBA 02/2013
1	Rituximab (Mabthera)FDA Link 02/2013
1	Timolol (Blocadren)FDA LinkGeneric 10/2008
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2007
1	Travoprost (Travatan)FDA Link 01/2007

4	Therapeutics 01/2021 - 02/2013